Global health and global governance of emerging biomedical technologies.
Ethics
Genetic Therapy
Policy
Reproductive Medicine
Journal
Journal of medical ethics
ISSN: 1473-4257
Titre abrégé: J Med Ethics
Pays: England
ID NLM: 7513619
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
28
09
2022
accepted:
27
01
2023
medline:
25
9
2023
pubmed:
8
2
2023
entrez:
7
2
2023
Statut:
ppublish
Résumé
Global governance of emerging, disruptive biomedical technologies presents a multitude of ethical problems. The recent paper by Shozi
Identifiants
pubmed: 36750323
pii: jme-2022-108673
doi: 10.1136/jme-2022-108673
doi:
Types de publication
Journal Article
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
719-720Commentaires et corrections
Type : CommentOn
Informations de copyright
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: The author is a member of the External Advisory Board for the Center for Embryonic Cell and Gene Therapy at Oregon Health and Science University. The author is a pro bono member and does not receive an honorarium for their service.